Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy

Mouhamed Nashawi, Mahmoud S. Ahmed, Toka Amin, Mujahed Abualfoul, Robert Chilton

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences